OPINION
¶ 1 Petitioners Krishna R. Dobson and Marvelle D. Anderson were convicted in municipal court of driving with an impermissible drug or its metabolite in a person’s body in violation of Arizona Revised Statutes (AR.S.) section 28-1381(A)(3) (2014).
FACTS AND PROCEDURAL HISTORY
¶ 2 Petitioners were charged with violating A.R.S. § 28-1381(A)(l) (driving or controlling a vehicle “[wjhile under the influence ... impaired to the slightest degree”) and AR.S. § 28-1381(A)(3) (driving or controlling a vehicle “[wjhile there is any drug defined in [AR.S. § ] 13-3401 or its metabolite in the
¶ 3 The superior court first considered Dobson’s appeal and affirmed, finding that “[hjaving a valid medical marijuana card is not a defense to” an (A)(3) charge. The superior court found the affirmative defense of A.R.S. § 28-1381(D) (“using a drug as prescribed by a” specified medical practitioner) does not apply to marijuana use. The superior court next found that A.R.S. § 36-2802(D) (providing “that a registered qualifying patient shall not be considered to be under the influence of marijuana solely because of the presence of metabolites or components of marijuana that appear in insufficient concentration to cause impairment”) did not apply to an (A)(3) charge. In affirming Anderson’s conviction, the superior court found “no reason to revisit its prior rulings” in Dobson’s appeal.
¶4 Petitioners then sought special action review. This court consolidated the matters sua sponte, accepted special action jurisdiction and took the consolidated matter under advisement with this written decision to follow.
DISCUSSION
I. Special Action Jurisdiction.
¶ 5 Special action jurisdiction is “highly discretionary,” Randolph v. Groscost,
¶ 6 Because these proceedings originated in municipal court, Petitioners have no right of appeal to this court. See A.R.S. § 22-375(B). The petitions present issues of statewide importance, some of which have not yet been addressed in any appellate decision, and that are likely to arise again. Accordingly, this court accepts special action jurisdiction. See Cicoria v. Cole,
II. The Merits.
A. Standard Of Review.
¶ 7 The municipal court “has considerable discretion in determining the relevance and admissibility of evidence.” State v. Amaya-Ruiz,
B. The Arizona Medical Marijuana Act.
¶ 8 Petitioners’ arguments implicate provisions of the Arizona Medical Marijuana Act (AMMA), passed by Arizona voters in November 2010 and codified at A.R.S. §§ 36-2801 to -2819. Under the AMMA, a registered qualifying patient with a debilitating medical condition may obtain a “[rjegistry
¶ 9 Petitioners assert they are registered qualifying patients who hold valid registry identification cards and used medical marijuana pursuant to a written certification from a physician under the AMMA
¶ 10 “ ‘[T]he best and most reliable index of a statute’s meaning is its language and, when the language is clear and unequivocal, it is determinative of the statute’s construction.” ” State ex rel. Montgomery v. Harris,
C. For An A.R.S. § 28-1381(A)(3) Charge, A.R.S. § 28-1381(0) Does Not Apply To Use Of Medical Marijuana Pursuant To A Written Certification Under The AMMA.
¶ 11 Petitioners stand convicted of violating (A)(3), which makes it “unlawful for a person to drive or be in actual physical control of a vehicle” in A’izona while “there is any drug defined in [AR.S.] § 13-3401 or its metabolite in the person’s body.” AR.S. § 28-1381(A)(3). Petitioners admit that marijuana and tetrahydrocannabinol (THC), an impairing active component of marijuana, are drugs as defined in AR.S. § 13-3401. See AR.S. § 13-3401(4)(b), (19); Harris,
¶ 12 The text of AR.S. § 28-1381(D) provides that “ ‘[a] person using a drug as prescribed by a medical practitioner licensed pursuant to [A.R.S. T]itle 32, [C]hapter 7 [podiatrist], 11 [dentist], 13 [medical doctor] or 17 [osteopath] is not guilty of violating’ 28-1381(A)(3).” Bayardi,
¶ 14 Among other things, as a Schedule I controlled substance, marijuana “cannot be dispensed under a prescription” by a medical practitioner. See United States v. Oakland Cannabis Buyers’ Coop.,
¶ 15 Petitioners also urge that the phrase “as prescribed” in A.R.S. § 28-1381(D) means something different than “prescription,” that “ ‘[pjrescribe’ is not defined in the statute and therefore it should be given its plain and ordinary meaning” and, accordingly, that “prescribed” should be read to include a “written certification” under the AMMA Athough the drafters of the AMMA could have used “as prescribed,” they did not do so. Petitioners cite no authority suggesting that “as prescribed” is intended to include a “written certification” as used in the AMMA Moreover, the phrase “as prescribed” used in AR.S. § 28-1381(D) was added by the Legislature in 2009 and, therefore, predates the November 2010 enactment of the AMMA See Bayardi,
¶ 16 Because “as prescribed” does not include a “written certification” under the AMMA, A.R.S. § 28-1381(D) does not provide an affirmative defense to an (A)(3) charge based on marijuana use. Accordingly, Petitioners have not shown the municipal court erred in finding their registry identification cards were inadmissible at trial under A.R.S. § 28-1381(D). See Amaya-Ruiz,
D. The AMMA Provisions Do Not Provide Immunity For An A.R.S. § 28-1381(A)(3) Charge.
¶ 17 Petitioners claim the AMMA contains two “immunity provisions,” which they allege “are clear on their face.” Petitioners first challenge the superior court’s rejection of their argument under AR.S. § 36-2802(D), which states that the AMMA
does not authorize any person to engage in, and does not prevent the imposition of any civil, criminal or other penalties for engaging in the following conduct: ... [ojperating, navigating or being in actual*209 physical control of any motor vehicle, aircraft or motorboat while under the influence of marijuana, except that a registered qualifying patient shall not be considered to be under the influence of marijuana solely because of the presence of metabolites or components of marijuana that appear in insufficient concentration to cause impairment.
A.R.S. § 36-2802(D). An (A)(3) charge, however, does not require that the defendant be “under the influence of marijuana,” id., or “require[ ] that the State prove impairment,” Harris,
¶ 18 Petitioners next rely on an AMMA provision stating that “[a] registered qualifying patient ... is not subject to arrest, prosecution or penalty in any manner ... [f]or the registered qualifying patient’s medical use of marijuana pursuant to [the AMMA], if the registered qualifying patient does not possess more than the allowable amount of marijuana.” AR.S. § 36-2811(B)(l). Petitioners argue their convictions were “strictly prohibited” by this provision, meaning they were “immune to prosecution” under (A)(3).
¶ 19 Petitioners’ (A)(3) convictions do not run afoul of AR.S. § 36-2811(B)(l). As applicable here, to be convicted of violating (A)(3), the State was required to show that Petitioners: (1) were driving or in actual physical control of a vehicle and (2) had marijuana or an impairing metabolite in their body. AR.S. § 28-1381(A)(3); see also Harris,
CONCLUSION
¶20 The affirmative defense available under AR.S. § 28-1381(D) does not apply to an AR.S. § 28-1381(A)(3) charge resulting from use of marijuana under the AMMA Similarly, neither AR.S. § 36-2811(B) nor AR.S. § 36-2802(D) provides immunity for defendants facing charges for driving with an impermissible drug or impairing metabolite in their bodies under A.R.S. § 28-1381(A)(3). Accordingly, the municipal court did not err in excluding from evidence at trial that Petitioners held medical marijuana cards and the superior court did not err in affirming those decisions. For these reasons, this court accepts jurisdiction but denies relief.
Notes
. Absent material revisions after the relevant dates, statutes and rules cited refer to the current version unless otherwise indicated.
. Although Oregon issued Dobson's medical marijuana card, it is undisputed that this card "has the same force and effect” as an Arizona registry identification card. See A.R.S. § 36-2804.03(0). The record suggests Dobson had a tetrahydro-cannabinol (THC) concentration of 8.5 nano-grams per milliliter (ngfynl) and Anderson had a THC concentration of 10 ng/ml, which the State notes far exceed the 5 ngfail levels "used in the two states that have set numerical limits” for THC-based impairment while driving. See Colo. Rev.Stat. Ann. § 42-4-1301(6)(a)(IV) (5.0 ng/ml of THC gives permissible inference of being under the influence); Wash. Rev.Code § 46.61.502(l)(b) (5.0 ngtal of THC within two hours of driving is per se limit).
. The superior court noted that A.R.S. § 36-2802(D) “might be relevant in a prosecution for a violation of" (A)(1), an issue this court need not address or resolve.
